Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
lobaplatin
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of Lobaplatin for Advanced Gastric Cancer (Summary Last Modified 02/95)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 to 75
Sponsor:
Protocol IDs:
MSKCC-94090A2
, NCI-V94-0570
2.
Phase II Study of Lobaplatin in Patients with Advanced Cancers of the Upper Aerodigestive Tract (Summary Last Modified 08/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-04912
3.
Phase II Study of Lobaplatin in Adults with Advanced Soft Tissue Sarcomas (Summary Last Modified 08/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-04914
4.
Phase II Study of Lobaplatin in Patients with Cancers of the Upper Aerodigestive Tract Resistant to Front-Line Treatment with Cisplatin or Carboplatin (Summary Last Modified 08/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-04913
5.
Phase II Study of Lobaplatin in Patients with Advanced Breast Cancer (Summary Last Modified 08/92)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
EORTC-04911
6.
Phase II Study of Lobaplatin in Patients with Advanced Urothelial Tract Tumors (Summary Last Modified 10/93)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
75 and under
Sponsor:
Protocol IDs:
EORTC-30931
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®
Mobile | Español
Mobile | Español
